Internal Medicine, Hematology & Oncology · New York, NY
NPI
1316926330
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
157 East 32nd Street, 2nd Floor
New York, NY, 10016
Phone (212) 689-6791
Groups this clinician bills Medicare through
Medicare paid, 2024
$798K
130,419 services
Medicare patients, 2024
564
Average age 76
Drug cost, 2024
$10.8M
2,109 prescriptions
Company payments, 2025
$826
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alec S Goldenberg was code J1756 (injection, iron sucrose, 1 mg), 45,628 times for 49 patients. In total Alec S Goldenberg billed 130,419 services in 91 codes, and Medicare paid $798K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1756 Injection, iron sucrose, 1 mg | Office | 45,628 | 49 | $0.01 | $355 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 15,624 | 58 | $0.09 | $1,403 |
| Q5101 Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | Office | 13,555 | 22 | $0.02 | $206 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 5,585 | 41 | $0.17 | $935 |
| 36415 Venipuncture Blood Collection | Office | 3,797 | 506 | $6.25 | $24K |
| 85025 Blood Count | Office | 3,768 | 499 | $7.61 | $29K |
| 96366 Intravenous Infusion, Hydration | Office | 2,656 | 107 | $18.12 | $48K |
| 99214 Office E&M - Established | Office | 2,470 | 537 | $106.93 | $264K |
| 99213 Office E&M - Established | Office | 2,311 | 153 | $79.56 | $184K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 2,036 | 112 | $0.50 | $1,009 |
| 96365 Intravenous Infusion, Hydration | Office | 1,453 | 106 | $56.68 | $82K |
| 96415 Chemotherapy Administration | Office | 963 | 44 | $24.93 | $24K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 883 | 39 | $0.21 | $183 |
| 96372 Injection Administration | Office | 741 | 68 | $12.60 | $9,335 |
| J1561 Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | Office | 703 | 14 | $0.49 | $346 |
By year: 2022 $537K for 91,268 services; 2023 $688K for 122,474 services; 2024 $798K for 130,419 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 3,797 | 506 | $6.25 | $24K |
| 85025 Blood Count | 3,768 | 499 | $7.61 | $29K |
Medicare prescription drug claims, 2024
In 2024, the drug Alec S Goldenberg prescribed most often to Medicare patients was Eliquis (Apixaban), with 102 prescriptions and refills. In total Alec S Goldenberg wrote 2,109 Medicare prescriptions that cost $10.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 102 | 128 | 22 | $66K |
| Procrit Epoetin Alfa | 100 | 100 | 27 | $409K |
| Pomalyst Pomalidomide | 85 | 85 | 11 | $1.1M |
| Hydroxyurea Generic | 76 | 114 | 13 | $1,430 |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 68 | 68 | Under 11 | $485K |
| Gazyva Obinutuzumab | 65 | 65 | 11 | $568K |
| Zarxio Filgrastim-Sndz | 64 | 64 | 19 | $80K |
| Bendamustine Hcl Generic | 59 | 59 | 13 | $395K |
| Jakafi Ruxolitinib Phosphate | 54 | 54 | Under 11 | $931K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 48 | 50 | Under 11 | $190K |
| Cyclophosphamide Generic | 45 | 45 | Under 11 | $31K |
| Xarelto Rivaroxaban | 44 | 61 | Under 11 | $34K |
| Retacrit Epoetin Alfa-Epbx | 44 | 49 | Under 11 | $88K |
| Fluconazole Generic | 44 | 50 | Under 11 | $601 |
| Enoxaparin Sodium Generic | 38 | 46 | 18 | $16K |
Brand drugs: 1,272 claims; generic drugs: - claims; opioid claims: 38.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alec S Goldenberg $826 ($826 in general payments such as food, travel and fees) from 21 companies. The largest payer was Pfizer Inc. with $107.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 5 | $107 |
| Aveo Pharmaceuticals, Inc. | 4 | $104 |
| Celgene Corporation BMY | 3 | $72.67 |
| Octapharma USA, Inc. | 2 | $52.91 |
| Alexion Pharmaceuticals, Inc. AZN | 2 | $52.48 |
| Abbvie Inc. ABBV | 2 | $46.72 |
| Acrotech Biopharma Inc. | 2 | $46.26 |
| Janssen Biotech, Inc. JNJ | 1 | $33.16 |
| Lilly USA, LLC LLY | 1 | $29.54 |
| Genzyme Corporation SNY | 1 | $28.86 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.